Canada Pension Plan Investment Board’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$164K Buy
53,300
+23,300
+78% +$98.9K ﹤0.01% 1601
2025
Q4
$108K Buy
+30,000
New +$131K ﹤0.01% 1795
2022
Q2
Sell
-182,000
Closed -$1.11M 1248
2022
Q1
$1.11M Buy
+182,000
New +$1.34M ﹤0.01% 826
2021
Q4
Sell
-300,000
Closed -$3.39M 1441
2021
Q3
$3.39M Buy
+300,000
New +$3.65M ﹤0.01% 749

Other funds holding ALT

Canada Pension Plan Investment Board's ALT Position: Q1 2026 in Review

Canada Pension Plan Investment Board increased its Altimmune (ALT) stake by 78% in Q1 2026, buying an estimated $98.9K and bringing the position to 53,300 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #1601.

Canada Pension Plan Investment Board first reported a position in ALT in Q3 2021 and has held it in 4 quarters since. The position peaked at $3.39M in Q3 2021. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Canada Pension Plan Investment Board held 53,300 shares of Altimmune worth $164K as of Q1 2026.
  • Canada Pension Plan Investment Board bought 23,300 Altimmune shares in Q1 2026, an estimated $98.9K.
  • Altimmune made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1601 holding.
  • Canada Pension Plan Investment Board first reported a position in Altimmune in Q3 2021 and has held it in 4 quarters since.
  • Canada Pension Plan Investment Board's Altimmune position peaked at $3.39M in Q3 2021.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.